Atkins Susan E. bought BTAI
August 12, 2026 · Form 4 insider transaction
Atkins Susan E. bought 17,000 shares of BioXcel Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$0.00
Total value
N/A
InsiderAtkins Susan E.
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after17,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable as to 33% of the underlying shares on the first anniversary of the grant date, and the remaining shares vest in two equal annual installments thereafter on the second and third anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through the relevant vesting dates.